NewLink Genetics Corporation
Latest round
- Series C
Last raised
- Jan 2008
Total raised
- $17M
Investors
- 5
About NewLink Genetics Corporation
Based in Ames, Iowa, NewLink Genetics Corporation is a late-stage, biopharmaceutical company focused on discovering, developing, and commercializing novel immunotherapeutic products to improve cancer treatment options for patients and physicians.
Who invested in NewLink Genetics Corporation
5 investors across 1 round
See all investors in NewLink Genetics Corporation
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
Jan 31, 2008
Amount
$17M
Investors
Questions about NewLink Genetics Corporation
Who invested in NewLink Genetics Corporation?
NewLink Genetics Corporation has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has NewLink Genetics Corporation raised?
NewLink Genetics Corporation has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did NewLink Genetics Corporation last raise money?
NewLink Genetics Corporation's most recent round on record is a Series C, in Jan 2008.
What does NewLink Genetics Corporation do?
Based in Ames, Iowa, NewLink Genetics Corporation is a late-stage, biopharmaceutical company focused on discovering, developing, and commercializing novel immunotherapeutic products to improve cancer treatment options for patients and physicians.
Where is NewLink Genetics Corporation headquartered?
NewLink Genetics Corporation is headquartered in Ames, US.
Which VCs invest in companies like NewLink Genetics Corporation?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at NewLink Genetics Corporation's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like NewLink Genetics Corporation? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.